DAVID STEFFIN to Receptors, Antigen, T-Cell
This is a "connection" page, showing publications DAVID STEFFIN has written about Receptors, Antigen, T-Cell.
Connection Strength
0.292
-
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma. Nat Med. 2025 Apr; 31(4):1125-1129.
Score: 0.175
-
Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells. Mol Ther. 2019 05 08; 27(5):900-901.
Score: 0.117